Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 28 06 2021
accepted: 27 12 2021
revised: 10 11 2021
pubmed: 6 2 2022
medline: 29 7 2022
entrez: 5 2 2022
Statut: ppublish

Résumé

Neovascular age-related macular degeneration (nAMD) is a major global cause of blindness. Whilst anti-vascular endothelial growth factor (anti-VEGF) treatment is effective, response varies considerably between individuals. Thus, patients face substantial uncertainty regarding their future ability to perform daily tasks. In this study, we evaluate the performance of an automated machine learning (AutoML) model which predicts visual acuity (VA) outcomes in patients receiving treatment for nAMD, in comparison to a manually coded model built using the same dataset. Furthermore, we evaluate model performance across ethnic groups and analyse how the models reach their predictions. Binary classification models were trained to predict whether patients' VA would be 'Above' or 'Below' a score of 70 one year after initiating treatment, measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The AutoML model was built using the Google Cloud Platform, whilst the bespoke model was trained using an XGBoost framework. Models were compared and analysed using the What-if Tool (WIT), a novel model-agnostic interpretability tool. Our study included 1631 eyes from patients attending Moorfields Eye Hospital. The AutoML model (area under the curve [AUC], 0.849) achieved a highly similar performance to the XGBoost model (AUC, 0.847). Using the WIT, we found that the models over-predicted negative outcomes in Asian patients and performed worse in those with an ethnic category of Other. Baseline VA, age and ethnicity were the most important determinants of model predictions. Partial dependence plot analysis revealed a sigmoidal relationship between baseline VA and the probability of an outcome of 'Above'. We have described and validated an AutoML-WIT pipeline which enables clinicians with minimal coding skills to match the performance of a state-of-the-art algorithm and obtain explainable predictions.

Identifiants

pubmed: 35122132
doi: 10.1007/s00417-021-05544-y
pii: 10.1007/s00417-021-05544-y
pmc: PMC9325856
doi:

Substances chimiques

Angiogenesis Inhibitors 0
Vascular Endothelial Growth Factor A 0
Ranibizumab ZL1R02VT79

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2461-2473

Subventions

Organisme : Medical Research Council
ID : MR/T000953/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T019050/1
Pays : United Kingdom
Organisme : moorfields eye charity career development award
ID : R190028A
Organisme : uk research & innovation future leaders fellowship
ID : MR/T019050/1

Informations de copyright

© 2022. The Author(s).

Références

Arch Ophthalmol. 1984 Nov;102(11):1640-2
pubmed: 6208888
Am J Ophthalmol. 2011 Aug;152(2):273-282.e3
pubmed: 21696700
Sci Rep. 2021 May 13;11(1):10286
pubmed: 33986429
Graefes Arch Clin Exp Ophthalmol. 2016 Oct;254(10):1873-1880
pubmed: 27262729
IEEE Trans Vis Comput Graph. 2020 Jan;26(1):56-65
pubmed: 31442996
Br J Ophthalmol. 2015 Feb;99(2):220-6
pubmed: 25193672
Ophthalmology. 2014 Nov;121(11):2204-11
pubmed: 25016366
Lancet Digit Health. 2019 Sep;1(5):e232-e242
pubmed: 33323271
Ophthalmol Retina. 2018 Jun;2(6):525-530
pubmed: 29938247
Science. 2019 Oct 25;366(6464):447-453
pubmed: 31649194
JAMA Ophthalmol. 2016 Feb;134(2):182-90
pubmed: 26661463
Eye (Lond). 2015 Dec;29(12):1561-9
pubmed: 26381099
J Med Internet Res. 2020 Nov 6;22(11):e24018
pubmed: 33027032
Artif Intell Med. 2020 Apr;104:101822
pubmed: 32499001
Acta Ophthalmol. 2019 Feb;97(1):91-98
pubmed: 30238648
Ophthalmology. 2018 Jul;125(7):1028-1036
pubmed: 29454659
Prog Retin Eye Res. 2016 Jan;50:1-24
pubmed: 26307399
Proc ACM Conf Health Inference Learn (2020). 2020 Apr;2020:151-159
pubmed: 33196064
Ophthalmol Retina. 2021 Nov;5(11):1074-1084
pubmed: 33516917
BMJ Open. 2020 Feb 25;10(2):e033898
pubmed: 32102816
Acta Ophthalmol. 2013 Sep;91(6):540-6
pubmed: 23171290
Ophthalmol Ther. 2020 Dec;9(4):725-737
pubmed: 32770474
Ophthalmology. 2009 Jan;116(1):57-65.e5
pubmed: 19118696
Int J Ophthalmol. 2016 Jan 18;9(1):119-23
pubmed: 26949621
Healthcare (Basel). 2020 Jul 31;8(3):
pubmed: 32751894
Diagnostics (Basel). 2019 Nov 07;9(4):
pubmed: 31703364
Ophthalmology. 1991 May;98(5 Suppl):741-56
pubmed: 2062510
Clin Ophthalmol. 2008 Mar;2(1):1-14
pubmed: 19668384
Saudi J Ophthalmol. 2011 Apr;25(2):145-58
pubmed: 23960916
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Sci Rep. 2020 Nov 11;10(1):19528
pubmed: 33177614
N Engl J Med. 2011 May 19;364(20):1897-908
pubmed: 21526923
Sci Rep. 2019 Jan 24;9(1):529
pubmed: 30679743
Am J Ophthalmol. 2008 Feb;145(2):239-248
pubmed: 18222192
Ophthalmology. 2021 May;128(5):693-705
pubmed: 32980396

Auteurs

Abdallah Abbas (A)

University College London Medical School, London, UK. Abdallah.abbas.18@ucl.ac.uk.

Ciara O'Byrne (C)

Moorfields Eye Hospital, London, UK.
School of Medicine, Trinity College, Dublin, Ireland.

Dun Jack Fu (DJ)

Moorfields Eye Hospital, London, UK.

Gabriella Moraes (G)

Moorfields Eye Hospital, London, UK.

Konstantinos Balaskas (K)

Moorfields Eye Hospital, London, UK.

Robbert Struyven (R)

Moorfields Eye Hospital, London, UK.

Sara Beqiri (S)

University College London Medical School, London, UK.

Siegfried K Wagner (SK)

NIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, London, UK.

Edward Korot (E)

Stanford University Byers Eye Institute, Palo Alto, CA, USA.

Pearse A Keane (PA)

NIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH